SNX32

gene
On this page

Also known as FLJ30934

Summary

SNX32 (sorting nexin 32, HGNC:26423) is a protein-coding gene on chromosome 11q13.1, encoding Sorting nexin-32 (Q86XE0). Involved in endosomal trafficking of cargo proteins, including transferrin-bound transferrin receptor (TFRC), cation-independent mannose-6-phosphate receptor (IGF2R) and epidermal growth factor receptor (EGFR).

Predicted to enable phosphatidylinositol binding activity. Predicted to be involved in retrograde transport, endosome to Golgi. Predicted to be located in cytoplasmic vesicle and cytosol. Predicted to be active in endosome.

Source: NCBI Gene 254122 — RefSeq curated summary.

At a glance

  • GWAS associations: 12
  • Clinical variants (ClinVar): 58 total
  • MANE Select transcript: NM_152760

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26423
Approved symbolSNX32
Namesorting nexin 32
Location11q13.1
Locus typegene with protein product
StatusApproved
AliasesFLJ30934
Ensembl geneENSG00000172803
Ensembl biotypeprotein_coding
OMIM621073
Entrez254122

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 7 retained_intron, 4 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000308342, ENST00000524729, ENST00000526972, ENST00000530101, ENST00000531503, ENST00000531795, ENST00000533236, ENST00000533298, ENST00000534387, ENST00000913492, ENST00000946609, ENST00000946610

RefSeq mRNA: 1 — MANE Select: NM_152760 NM_152760

CCDS: CCDS8113

Canonical transcript exons

ENST00000308342 — 13 exons

ExonStartEnd
ENSE000012356596585132865851403
ENSE000012357396585328265853701
ENSE000021707346583396365834101
ENSE000025018286585164065851679
ENSE000034949266585015065850271
ENSE000035130496585075165850855
ENSE000035306576584947865849582
ENSE000035755506585043165850554
ENSE000035870686584992065850030
ENSE000036120006585263065852789
ENSE000036494266585246565852551
ENSE000036578006585105565851160
ENSE000036749616585287365852958

Expression profiles

Bgee: expression breadth ubiquitous, 163 present calls, max score 93.56.

FANTOM5 (CAGE): breadth broad, TPM avg 1.9727 / max 143.5361, expressed in 609 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1152141.4526524
1152150.5201193

Top tissues by expression

244 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right frontal lobeUBERON:000281093.56gold quality
Brodmann (1909) area 9UBERON:001354091.58gold quality
nucleus accumbensUBERON:000188290.99gold quality
caudate nucleusUBERON:000187390.31gold quality
anterior cingulate cortexUBERON:000983590.30gold quality
putamenUBERON:000187489.52gold quality
dorsolateral prefrontal cortexUBERON:000983488.64gold quality
prefrontal cortexUBERON:000045187.20gold quality
cortical plateUBERON:000534386.77gold quality
amygdalaUBERON:000187686.63gold quality
neocortexUBERON:000195086.50gold quality
frontal cortexUBERON:000187086.11gold quality
right hemisphere of cerebellumUBERON:001489086.01gold quality
cerebellar hemisphereUBERON:000224584.71gold quality
cerebral cortexUBERON:000095684.51gold quality
cerebellar cortexUBERON:000212984.49gold quality
cerebellumUBERON:000203782.83gold quality
hypothalamusUBERON:000189882.55gold quality
forebrainUBERON:000189082.47gold quality
primary visual cortexUBERON:000243682.06gold quality
brainUBERON:000095581.72gold quality
Ammon’s hornUBERON:000195481.41gold quality
temporal lobeUBERON:000187179.47gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047377.79gold quality
spermCL:000001977.71silver quality
occipital lobeUBERON:000202176.55gold quality
C1 segment of cervical spinal cordUBERON:000646976.40gold quality
ganglionic eminenceUBERON:000402375.15gold quality
superior frontal gyrusUBERON:000266174.92gold quality
substantia nigraUBERON:000203874.57gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-CURD-112yes15172.68
E-MTAB-9543yes3567.33
E-ANND-3yes18.96
E-MTAB-8060no81.20

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): NR1I2

miRNA regulators (miRDB)

25 targeting SNX32, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4455100.0065.481587
HSA-MIR-4747-5P100.0067.902681
HSA-MIR-5196-5P100.0067.982761
HSA-MIR-6783-3P99.8967.922059
HSA-MIR-1343-3P99.8966.781815
HSA-MIR-3151-5P99.8663.831069
HSA-MIR-444799.8567.812900
HSA-MIR-431999.7669.832586
HSA-MIR-187-5P99.7470.261404
HSA-MIR-670-5P99.6769.941565
HSA-MIR-486-3P99.5166.821901
HSA-MIR-125A-5P99.3670.591640
HSA-MIR-125B-5P99.3670.361662
HSA-MIR-145-3P99.3367.66764
HSA-MIR-6852-5P99.1766.692073
HSA-MIR-876-3P98.7668.23945
HSA-MIR-323A-5P98.5965.13651
HSA-MIR-6804-5P98.3965.771084
HSA-MIR-126298.1766.52757
HSA-MIR-3127-5P97.5265.24786
HSA-MIR-391896.1364.651300
HSA-MIR-443595.9065.471201
HSA-MIR-468395.2965.98631
HSA-MIR-6732-5P93.9764.65422
HSA-MIR-450A-5P93.8964.5750

Literature-anchored findings (GeneRIF, showing 1)

  • SNX32 Regulates Sorting and Trafficking of Activated EGFR to the Lysosomal Degradation Pathway. (PMID:39073202)

Cross-species orthologs

9 orthologs

OrganismSymbolGene ID
danio_reriosi:dkey-28n18.9ENSDARG00000097193
mus_musculusSnx32ENSMUSG00000056185
rattus_norvegicusSnx32ENSRNOG00000026527
drosophila_melanogasterSnx1FBGN0031534
drosophila_melanogasterSnx6FBGN0032005
drosophila_melanogasterSH3PX1FBGN0040475
caenorhabditis_elegansWBGENE00003086
caenorhabditis_elegansWBGENE00004927
caenorhabditis_elegansWBGENE00013354

Paralogs (15): SNX11 (ENSG00000002919), SNX1 (ENSG00000028528), SNX10 (ENSG00000086300), SNX5 (ENSG00000089006), SNX8 (ENSG00000106266), SNX3 (ENSG00000112335), SNX4 (ENSG00000114520), SNX6 (ENSG00000129515), SNX9 (ENSG00000130340), SNX12 (ENSG00000147164), SNX30 (ENSG00000148158), SNX7 (ENSG00000162627), SNX33 (ENSG00000173548), SNX18 (ENSG00000178996), SNX2 (ENSG00000205302)

Protein

Protein identifiers

Sorting nexin-32Q86XE0 (reviewed: Q86XE0)

Alternative names: Sorting nexin-6B

All UniProt accessions (1): Q86XE0

UniProt curated annotations — full annotation on UniProt →

Function. Involved in endosomal trafficking of cargo proteins, including transferrin-bound transferrin receptor (TFRC), cation-independent mannose-6-phosphate receptor (IGF2R) and epidermal growth factor receptor (EGFR). Functions redundantly with other BAR domain-containing sorting nexins in endosome to trans-Golgi network transport of IGF2R. Regulates in coordination with SNX5 sorting and trafficking of EGF-activated EGFR to multivesicular bodies for lysosomal degradation. Plays an essential role in neurite outgrowth, controlling basigin/EMMPRIN (BSG) trafficking to the cell surface.

Subunit / interactions. Interacts with BAR domain-containing sorting nexins SNX1, SNX2, SNX4, SNX5 and SNX6. Interacts (via PX domain) with cargo proteins transferrin-bound TFRC, IGF2R and BSG; the interaction regulates their intracellular trafficking. Interacts with EGFR; the interaction is required for endolysosomal EGFR trafficking.

Subcellular location. Cell membrane. Early endosome. Golgi apparatus. trans-Golgi network. Recycling endosome. Late endosome.

Similarity. Belongs to the sorting nexin family.

Isoforms (2)

UniProt IDNamesCanonical?
Q86XE0-11yes
Q86XE0-22

RefSeq proteins (1): NP_689973* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001683PX_domDomain
IPR014637SNX5/SNX6/SNX32Family
IPR015404Vps5_CDomain
IPR027267AH/BAR_dom_sfHomologous_superfamily
IPR036871PX_dom_sfHomologous_superfamily

Pfam: PF00787, PF09325

UniProt features (20 total): helix 6, strand 3, sequence variant 3, splice variant 2, mutagenesis site 2, chain 1, domain 1, sequence conflict 1, coiled-coil region 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
6E8RX-RAY DIFFRACTION2.27

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q86XE0-F189.430.72

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Mutagenesis-validated functional residues (2):

PositionPhenotype
131loss of interaction with tfrc, igf2r and bsg. does not affect interaction with snx1.
256decreased interaction with snx5.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 95 (showing top): GOBP_REGULATION_OF_AUTOPHAGY, GOBP_LYSOSOMAL_TRANSPORT, GOBP_ENDOSOME_ORGANIZATION, GOBP_NEURON_PROJECTION_EXTENSION, GOBP_VESICLE_ORGANIZATION, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT, GOBP_GROWTH, GOBP_VACUOLAR_TRANSPORT, GOBP_NEUROGENESIS, GOBP_VESICLE_MEDIATED_TRANSPORT, chr11q13, GOBP_MACROAUTOPHAGY, GOCC_TRANS_GOLGI_NETWORK, GOBP_REGULATION_OF_CATABOLIC_PROCESS

GO Biological Process (6): protein transport (GO:0015031), endosomal transport (GO:0016197), regulation of macroautophagy (GO:0016241), endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510), retrograde transport, endosome to Golgi (GO:0042147), neuron projection extension (GO:1990138)

GO Molecular Function (3): dynactin binding (GO:0034452), phosphatidylinositol binding (GO:0035091), protein binding (GO:0005515)

GO Cellular Component (10): endosome (GO:0005768), early endosome (GO:0005769), late endosome (GO:0005770), trans-Golgi network (GO:0005802), cytosol (GO:0005829), plasma membrane (GO:0005886), retromer complex (GO:0030904), early endosome membrane (GO:0031901), recycling endosome (GO:0055037), tubular endosome (GO:0097422)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
endosome4
endomembrane system2
cellular anatomical structure2
transport1
intracellular protein localization1
establishment of protein localization1
vesicle-mediated transport1
intracellular transport1
regulation of autophagy1
macroautophagy1
endosome to lysosome transport1
endosome transport via multivesicular body sorting pathway1
intercellular transport1
endosomal transport1
cytosolic transport1
developmental cell growth1
neuron projection morphogenesis1
developmental growth involved in morphogenesis1
cytoskeletal protein binding1
anion binding1
binding1
cytoplasmic vesicle1
Golgi apparatus subcompartment1
cytoplasm1
membrane1
cell periphery1
membrane protein complex1
early endosome1
endosome membrane1

Protein interactions and networks

STRING

660 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SNX32SNX2P82862980
SNX32SNX1Q13596965
SNX32SNX5Q9Y5X3800
SNX32SNX6Q9UNH7712
SNX32SNX7Q9UNH6668
SNX32VPS29Q9UBQ0658
SNX32SNX8Q9Y5X2643
SNX32SNX33Q8WV41637
SNX32VPS26AO75436633
SNX32SNX27Q96L92620
SNX32VPS35Q96QK1599
SNX32VPS26BQ4G0F5598
SNX32SNX3O60493584
SNX32SNX18Q96RF0571
SNX32SNX4O95219568

IntAct

44 interactions, top by confidence:

ABTypeScore
SNX1SNX32psi-mi:“MI:0915”(physical association)0.870
SNX32SNX2psi-mi:“MI:0914”(association)0.740
SNX2SNX32psi-mi:“MI:0915”(physical association)0.740
SNX1SNX2psi-mi:“MI:0914”(association)0.740
SNX32TFIP11psi-mi:“MI:0915”(physical association)0.560
SNX32NME7psi-mi:“MI:0915”(physical association)0.560
SNX32SPANXB1psi-mi:“MI:0915”(physical association)0.560
GRXCR1SNX32psi-mi:“MI:0915”(physical association)0.560
EML2SNX32psi-mi:“MI:0915”(physical association)0.560
SNX32MNS1psi-mi:“MI:0915”(physical association)0.560
C22orf39SNX32psi-mi:“MI:0915”(physical association)0.560
incESNX2psi-mi:“MI:0914”(association)0.430
SNX30SNX32psi-mi:“MI:0915”(physical association)0.400
Mpsi-mi:“MI:0914”(association)0.350
SNX32CHMP2Apsi-mi:“MI:0914”(association)0.350
SNX32SNX2psi-mi:“MI:0915”(physical association)0.000
SNX32SNX1psi-mi:“MI:0915”(physical association)0.000
SNX32TFIP11psi-mi:“MI:0915”(physical association)0.000
SNX1SNX32psi-mi:“MI:0915”(physical association)0.000
NME7SNX32psi-mi:“MI:0915”(physical association)0.000

BioGRID (38): SNX32 (Two-hybrid), SNX1 (Two-hybrid), SNX1 (Affinity Capture-MS), SNX6 (Affinity Capture-MS), RAD51 (Affinity Capture-MS), IFFO1 (Affinity Capture-MS), SNX2 (Affinity Capture-MS), CEP44 (Affinity Capture-MS), RNF40 (Affinity Capture-MS), BRCA2 (Affinity Capture-MS), PIK3R1 (Affinity Capture-MS), TEX11 (Two-hybrid), TSG101 (Two-hybrid), SNX32 (Two-hybrid), SNX32 (Two-hybrid)

ESM2 similar proteins: A0A1B7YDZ4, B1H267, I1RXT2, O14243, O60107, O74960, O94447, P0CR58, P0CR59, P0CR62, P0CR63, P0CR64, P0CR65, P32912, P32913, P40531, P40959, P47057, Q09746, Q10253, Q28GP7, Q3ZBM5, Q4PHC3, Q4VAA7, Q4WQI6, Q522W5, Q5B797, Q5R613, Q6C238, Q6C9X0, Q6CGJ5, Q6CHY6, Q6CTQ0, Q6CUC4, Q6FPT9, Q6NRL2, Q6P8X1, Q759T1, Q75B65, Q75C43

Diamond homologs: B1H267, Q3ZBM5, Q4V7P7, Q5R613, Q6P8X1, Q80ZJ7, Q86XE0, Q9D8U8, Q9UNH7, Q9Y5X3, B9DFS6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

58 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance51
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2581 predictions. Top by Δscore:

VariantEffectΔscore
11:65850010:GAGGA:Gdonor_gain1.0000
11:65850012:G:GTdonor_gain1.0000
11:65850012:GGA:Gdonor_gain1.0000
11:65850013:G:GTdonor_gain1.0000
11:65850013:GA:Gdonor_gain1.0000
11:65850015:G:GGdonor_gain1.0000
11:65850031:G:GGdonor_gain1.0000
11:65850036:G:GTdonor_gain1.0000
11:65850270:GC:Gdonor_gain1.0000
11:65850272:G:GGdonor_gain1.0000
11:65850430:GGGA:Gacceptor_gain1.0000
11:65850551:GGAT:Gdonor_gain1.0000
11:65850552:G:GTdonor_gain1.0000
11:65850560:C:Gdonor_gain1.0000
11:65850741:T:TAacceptor_gain1.0000
11:65850750:GCT:Gacceptor_gain1.0000
11:65851159:GT:Gdonor_gain1.0000
11:65851161:G:GGdonor_gain1.0000
11:65851396:C:Gdonor_gain1.0000
11:65851404:G:GGdonor_gain1.0000
11:65852443:A:AGacceptor_gain1.0000
11:65852444:G:GGacceptor_gain1.0000
11:65852624:TCCTA:Tacceptor_loss1.0000
11:65852625:CCTAG:Cacceptor_loss1.0000
11:65852626:CTAG:Cacceptor_loss1.0000
11:65852627:TAGG:Tacceptor_loss1.0000
11:65852628:A:AGacceptor_gain1.0000
11:65852628:A:Tacceptor_loss1.0000
11:65852629:G:GGacceptor_gain1.0000
11:65852629:G:Tacceptor_loss1.0000

AlphaMissense

2630 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:65849565:T:CF42L1.000
11:65849567:C:AF42L1.000
11:65849567:C:GF42L1.000
11:65849572:T:AV44D1.000
11:65850447:T:CF131L1.000
11:65850449:T:AF131L1.000
11:65850449:T:GF131L1.000
11:65849566:T:CF42S0.999
11:65849977:T:CF67L0.999
11:65849978:T:CF67S0.999
11:65849979:C:AF67L0.999
11:65849979:C:GF67L0.999
11:65849987:T:CL70P0.999
11:65850163:C:AP89H0.999
11:65850177:T:CF94L0.999
11:65850179:T:AF94L0.999
11:65850179:T:GF94L0.999
11:65850257:G:CK120N0.999
11:65850257:G:TK120N0.999
11:65850435:T:CY127H0.999
11:65850436:A:GY127C0.999
11:65850439:T:CL128P0.999
11:65850448:T:CF131S0.999
11:65850452:G:CK132N0.999
11:65850452:G:TK132N0.999
11:65850460:T:AV135D0.999
11:65850534:T:CF160L0.999
11:65850536:T:AF160L0.999
11:65850536:T:GF160L0.999
11:65852499:T:CL287P0.999

dbSNP variants (sampled 300 via entrez): RS1000042091 (11:65850810 G>A,C), RS1000181791 (11:65834582 T>G), RS1000239290 (11:65839629 C>G), RS1000311415 (11:65839329 A>C), RS1000519348 (11:65833146 G>A,T), RS1000585621 (11:65840103 C>T), RS1000594143 (11:65834189 CTGTG>C,CTG,CTGTGTG,CTGTGTGTG), RS1000645432 (11:65840750 G>A), RS1000660508 (11:65832718 C>T), RS1000823349 (11:65833454 G>A), RS1000918035 (11:65834382 T>G), RS1000956254 (11:65840402 G>A,T), RS1001019694 (11:65848003 G>A), RS1001046107 (11:65847530 C>T), RS1001194170 (11:65839666 AT>A)

Disease associations

OMIM: gene MIM:621073 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

12 associations (top):

StudyTraitp-value
GCST001725_13Inflammatory bowel disease3.000000e-10
GCST001937_15Breast cancer9.000000e-12
GCST002481_8Acne (severe)3.000000e-11
GCST005790_23Rosacea symptom severity1.000000e-08
GCST006408_13Allergic sensitization3.000000e-07
GCST008362_125Birth weight2.000000e-08
GCST90002398_198Neutrophil count4.000000e-12
GCST90002402_353Platelet count2.000000e-10
GCST90002407_330White blood cell count7.000000e-18
GCST90020025_1881Waist-to-hip ratio adjusted for BMI7.000000e-12
GCST90020027_1497Waist-hip index4.000000e-12
GCST90020029_331Waist circumference adjusted for body mass index2.000000e-11

EFO canonical traits (7, from GWAS)

EFO IDTrait name
EFO:0009180rosacea severity measurement
EFO:0005298allergic sensitization measurement
EFO:0004344birth weight
EFO:0004833neutrophil count
EFO:0004309platelet count
EFO:0007788BMI-adjusted waist-hip ratio
EFO:0007789BMI-adjusted waist circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

10 total (human), top 10 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Sdecreases expression, decreases methylation2
aristolochic acid Iincreases expression1
GSK-J4decreases expression1
triphenyl phosphateaffects expression1
bisphenol Adecreases expression1
sodium arsenitedecreases expression1
Acetaminophendecreases expression1
Arsenicaffects methylation1
Benzo(a)pyreneincreases methylation1
Cadmium Chloridedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.